Use of perospirone for obesity and diabetes mellitus in patients with schizophrenia: three case reports

被引:2
作者
Nishida, M
Nakamura, M
机构
[1] Jichi Med Sch, Dept Psychiat, Minami Kawachi, Tochigi, Japan
[2] Ibaraki Prefectural Tomobe Hosp, Ibaraki, Japan
关键词
perospirone; obesity; schizophrenia; diabetes mellitus;
D O I
10.1097/00004850-200401000-00008
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We report that perospirone may have had positive effects on the obesity of three patients with schizophrenia and on the fasting blood sugar (FBS) and HbA1C of two of them who had type 2 diabetes mellitus. (C) 2004 Lippincott Williams Wilkins.
引用
收藏
页码:41 / 43
页数:3
相关论文
共 13 条
[1]  
Allison DB, 1999, AM J PSYCHIAT, V156, P1686
[2]   Obesity and related metabolic abnormalities during antipsychotic drug administration: Mechanisms, management and research perspectives [J].
Baptista, T ;
Kin, NMKNY ;
Beaulieu, S ;
de Baptista, EA .
PHARMACOPSYCHIATRY, 2002, 35 (06) :205-219
[3]   Biotransformation of post-clozapine antipsychotics - Pharmacological implications [J].
Caccia, S .
CLINICAL PHARMACOKINETICS, 2000, 38 (05) :393-414
[4]  
Casey DE, 2001, J CLIN PSYCHIAT, V62, P4
[5]  
de Paulis Tomas, 2002, Curr Opin Investig Drugs, V3, P121
[6]   PHARMACOLOGICAL ACTIONS OF SM-9018, A NEW NEUROLEPTIC DRUG WITH BOTH POTENT 5-HYDROXYTRYPTAMINE-2 AND DOPAMINE-2 ANTAGONISTIC ACTIONS [J].
HIROSE, A ;
KATO, T ;
OHNO, Y ;
SHIMIZU, H ;
TANAKA, H ;
NAKAMURA, M ;
KATSUBE, J .
JAPANESE JOURNAL OF PHARMACOLOGY, 1990, 53 (03) :321-329
[7]   A 28-week comparison of ziprasidone and haloperidol in outpatients with stable schizophrenia [J].
Hirsch, SR ;
Kissling, W ;
Bäuml, J ;
Power, A ;
O'Connor, R .
JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (06) :516-+
[8]   BINDING PROFILE OF SM-9018, A NOVEL ANTIPSYCHOTIC CANDIDATE [J].
KATO, T ;
HIROSE, A ;
OHNO, Y ;
SHIMIZU, H ;
TANAKA, H ;
NAKAMURA, M .
JAPANESE JOURNAL OF PHARMACOLOGY, 1990, 54 (04) :478-481
[9]  
Kawachi I, 1999, J CLIN PSYCHIAT, V60, P5
[10]  
MURASAKI M, 2001, RINSHOSEISHINYAKURI, V4, P849